Literature DB >> 15011643

T-1249 development suspended.

Bob Huff.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 15011643

Source DB:  PubMed          Journal:  GMHC Treat Issues        ISSN: 1077-1824


× No keyword cloud information.
  2 in total

1.  Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.

Authors:  Atze T Das; Chris E Baldwin; Monique Vink; Ben Berkhout
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Selection of T1249-resistant human immunodeficiency virus type 1 variants.

Authors:  Dirk Eggink; Christopher E Baldwin; Yiqun Deng; Johannes P M Langedijk; Min Lu; Rogier W Sanders; Ben Berkhout
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.